The landscape of dementia analysis has advanced substantially with the advent of complex biomarkers, which includes amyloid PET scans, tau imaging, and blood-centered tests that could detect Alzheimer's pathology decades just before signs or symptoms arise. Whilst these technological developments characterize remarkable progress in knowledge neurod